How to Buy Iradimed Stock
Iradimed Corp
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
Iradimed stock last closed at $41.86, up 0.94% from the previous day, and has increased 2.45% in one year. It has overperformed other stocks in the Medical Devices industry by 0.18 percentage points. Iradimed stock is currently +15.89% from its 52-week low of $36.12, and -17.98% from its 52-week high of $51.04.
There are currently 12.66M shares of IRMD outstanding. The market cap of IRMD is $530.07M. In the last 24 hours, 27,053 IRMD shares were traded.
How to Buy Iradimed Stock
Wondering how to invest in Iradimed stock? Here's how.
- Choose where to buy Iradimed stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Iradimed stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your payment method and add your information.
- Evaluate Iradimed stock: The Iradimed ticker symbol is IRMD. Is Iradimed stock a good investment? Should you buy shares of IRMD? How do IRMD's underlying business fundamentals look? Do top analysts think Iradimed is a good buy? Why has IRMD's stock price moved recently? (Hint: Our stock market research website can help you evaluate if IRMD is a good stock to buy).
- Make your IRMD buy order: Decide if you will purchase IRMD shares at the current market price or use a limit order to buy IRMD stock at a given price.
- Watch your IRMD investment: Create a watchlist to important notifications about your position in Iradimed shares.
Step 1: Choose where to buy Iradimed stock
You will need an online brokerage account in order to access the NASDAQ market and buy IRMD stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you are able to invest in IRMD today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start your new trading account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have created your account on the best stock app, your next step is to transfer the money for your investment:
Check out this video walkthrough for more details transferring funds into your investment account.
Step 4: Evaluate Iradimed stock
After you have selected the best place to buy Iradimed stock, it's important to research their stock prior to buying, so you truly understand the risk as well as the upside.
Iradimed stock data
Iradimed Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on IRMD's stock page.
What is the fair value of IRMD stock?
Analysts use many financial metrics, analyses, models, and charts to gauge IRMD's true value.
Using relative valuations metrics:
- IRMD could be overvalued based on its P/E ratio of 30.78x, relative to Medical Devices industry P/E ratio of 28.63x
- IRMD may be overvalued based on its P/B ratio of 7.42x, relative to Medical Devices industry P/B ratio of 3.7x
- IRMD may be overvalued based on its PEG ratio of 2.32x
You can do additional valuation analysis on IRMD's stock here.
IRMD Financial Summary
Positive Health Checks:
- IRMD's operating cash flow of $13.47M allows it to safely service it's debt of $2.04M.
- There are more short-term assets than long-term liabilities on the IRMD balance sheet.
- IRMD profit margin has gone up from 24.1% to 26.2% in the past year.
- IRMD earnings of $21.74M is not enough to cover its interest payments.
- IRMD has a low debt to equity ratio of 0.29.
- There are more short-term assets than short-term liabilities on the IRMD balance sheet.
Negative Health Checks:
- Total IRMD debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy IRMD stock
Out of 1 Equities analysts who monitor IRMD, the consensus analyst rating on IRMD is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Iradimed stock forecast page.
IRMD Momentum
IRMD Performance Metrics
Last year, IRMD earnings were $17.19M. During the past 5 year, IRMD's earnings have gone up by 18.18% per year. This was faster than the Medical Devices industry average of 8.55%.
Last year, IRMD revenue was $65.56M. During the last five year, IRMD's revenue has gone up by 16.59% per year. This was faster than the Medical Devices industry average of 13.26%.
Dig into IRMD's earnings and revenue performance here.
What are IRMD insiders up to?
In the last year, insiders at IRMD have sold more shares than they have bought.
Roger E. Susi, CEO PRESIDENT CHAIRMAN of IRMD, was the latest IRMD insider to sell. They sold $232,545.00 worth of IRMD stock on Dec 27, 2023.
Get more info about who owns IRMD stock here.
Can I get consistent income from IRMD stock?
Iradimed pays a dividend of 1.51%, compared to the Medical Devices industry's average dividend yield of 1.58%. If you owned $1,000 worth of IRMD stock, you would have received $15.05 in the past 12 months.
Dig into more data about Iradimed dividend yield and history here.
IRMD Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your IRMD buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, use a limit order.
Hit the Open button and eToro will execute your order.
If you need more help with buying stocks on eToro, watch the helpful video below:
Step 6: Watch your IRMD investment
Now that you own some IRMD stock, you'll want to keep up with your shares.
Start a watchlist to keep tabs on your IRMD stock.
IRMD Feed
How to Buy Stock in Iradimed
To reiterate, here are the 6 steps you need to take to buy Iradimed stock right now:
- Choose where to buy Iradimed stock
- Sign up for your brokerage account
- Put funds into your brokerage account
- Evaluate Iradimed stock
- Make your IRMD buy order
- Watch your IRMD investment
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Iradimed, create a watchlist on WallStreetZen today.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.